Streetbeat News

Earnings

NAUT

Nautilus Biotechnology (NASDAQ:NAUT) reported Q4 2023 GAAP EPS of $(0.14), surpassing the $(0.15) estimate by 6.67%. However, this represents a 27.27% increase in losses compared to $(0.11) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:10 pm

QRTEB

Qurate Retail (NASDAQ:QRTEB) reported a significant increase in its Q4 adjusted EPS to $0.22, up from a loss of $(0.05) YoY. However, sales decreased by 10.86% to $3.14B from $3.53B YoY.

Portfolio Pulse from totan@benzinga.com

February 28, 2024 | 12:09 pm

DIN

Dine Brands Global reported Q4 adjusted earnings of $1.40 per share, surpassing the $1.15 estimate, and sales of $206.30M, slightly above the $206.14M estimate. This represents a 4.48% increase in earnings per share over the previous year, despite a 0.80% decrease in sales.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:09 pm

GERN

Geron (NASDAQ:GERN) reported Q4 earnings with a loss of $(0.09) per share, beating the $(0.10) estimate. However, sales of $23K missed the $70K estimate significantly. The company has $378.1M in cash and equivalents, expected to fund operations into Q3 2025.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:08 pm

NXST

Nexstar Media Group reported a Q4 EPS of $3.32, down from $5.30 year-over-year. Sales reached $1.30B, missing the $1.31B estimate.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:08 pm

FOLD

Amicus Therapeutics forecasts an 11-16% revenue growth for Galafold in 2024 at constant exchange rates (CER) and expects to achieve full-year non-GAAP profitability in the same year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:07 pm

MNMD

MindMed reported a 2023 EPS of $(2.33) and a cash balance of $99.7 million as of December 31. The financial results indicate a significant loss per share but a strong cash position.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:07 pm

BAND

Bandwidth Inc. projects a 16% increase in revenue and a 50% growth in profitability for the year 2024, indicating a positive outlook for the company's financial performance.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:07 pm

INVZ

Innoviz Technologies reported a Q4 EPS of $(0.18), an improvement from $(0.25) YoY. Sales reached $14.92M, surpassing the $11.20M estimate.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:07 pm

PERF

Perfect (NYSE:PERF) reported Q4 2023 adjusted EPS of $0.02, surpassing the $(0.01) estimate, with sales of $14.12M exceeding the $13.91M forecast. This represents a 27.58% increase in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 12:07 pm